Severe Acute Respiratory Syndrome: all 386 studies
Page 4 of 4. Open to participants first (14), then studies with results posted, then the rest; newest registration first within each.
- Characteristics of Patients With COVID-19 in Meta State, ColombiaWithdrawnNCT04456426
- NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 InfectionStatus unknownNCT04452565Phase 2/3
- Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard Treatment in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19).WithdrawnNCT04452474Phase 2/3
- A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to (SARS-CoV-2) COVID-19 PandemicCompletedNCT04444700Phase 3
- Nitric Oxide Releasing Solution to Treat and Prevent Exacerbation of Mild COVID-19 InfectionWithdrawnNCT04443868Phase 2
- Glycine Supplement for Severe COVID-19TerminatedNCT04443673Not applicable
- Cardiovascular Implications of COVID-19TerminatedNCT04435457
- Best Supportive Care With or Without Low Dose Whole Lung Radiation Therapy for the Treatment of COVID-19Active, not recruitingNCT04433949Phase 3
- Obesity and Mortality of Critically Ill Patients With COVID-19CompletedNCT04425213
- COVID-19 Related Health and Infection Control Practices Among DentistsCompletedNCT04423770
- Tocilizumab in Coronavirus-19 Positive PatientsStatus unknownNCT04423042Phase 3
- Preemptive Therapy for SARS-Coronavirus-2 (COVID-19 PEP Canada)TerminatedNCT04421664Phase 3
- Investigational COVID-19 Convalescent Plasma Infusion for Severely or Life-threateningly Ill COVID-19 PatientsNo longer availableNCT04420988
- Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe DiseaseCompletedNCT04419025Phase 2
- Covid-19 and Diabetes in West of AlgeriaStatus unknownNCT04412746
- Intermediate IND Severe Illness COVID-19 CPWithdrawnNCT04411602Phase 1
- TAF/FTC for Pre-exposure Prophylaxis of COVID-19 in Healthcare Workers (CoviPrep Study)TerminatedNCT04405271Phase 3
- Hydroxychloroquine and Lopinavir/ Ritonavir to Improve the Health of People With COVID-19: "The Hope Coalition - 1"Status unknownNCT04403100Phase 3
- RT-PCR on Conjunctival Sample for the Detection of SARS-CoV-2 in Patients With Covid-19Status unknownNCT04397666Not applicable
- Extracorporeal Membrane Oxygenation (ECMO) and Coronavirus Disease (COVID) 19CompletedNCT04397588
- A Study of ResCure™ to Treat COVID-19 InfectionWithdrawnNCT04395716Phase 1
- COVid-19: Awake Proning and High-flow Nasal Cannula in respiratorY DistrEssCompletedNCT04395144Not applicable
- Low Dose Radiotherapy in COVID-19 PneumoniaStatus unknownNCT04390412Phase 1/2
- Malaysian COVID-19 Anosmia Study (Phase 1) - A Nationwide Multicentre Cross-Sectional StudyCompletedNCT04390165
- Combination Therapy With Isotretinoin and Tamoxifen Expected to Provide Complete Protection Against Severe Acute Respiratory Syndrome CoronavirusStatus unknownNCT04389580Phase 2
- Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19SuspendedNCT04386070Phase 3
- Trial of Alpha One Antitrypsin Inhalation in Treating Patient With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)Status unknownNCT04385836Early Phase 1
- Use of High Flow Nasal Cannula Oxygen and Covid-19 Acute Hypoxemic Respiratory FailureCompletedNCT04385823
- HDL Target of CoViD19 ? Analysis on the Caregivers of the Reunion University HospitalStatus unknownNCT04384705
- Malaysian COVID-19 Anosmia Study (Phase 2) - A Nationwide Multicentre Case-Control StudyStatus unknownNCT04384042
- COVIDNOCHE Trial (HFNO Versus CPAP Helmet) in COVID-19 PneumoniaWithdrawnNCT04381923Not applicable
- Norwegian SARS-CoV-2 Study - Virological, Clinical and Immunological Characterisation of COVID-19Status unknownNCT04381819
- Vagus Nerve Stimulation ARDS Prevention Trial for COVID-19 Hospitalized PatientsCompletedNCT04379037Not applicable
- Host-pathogen Interactions During SARS-CoV-2 InfectionCompletedNCT04376476Not applicable
- Monocytes and NK Cells Activity in Covid-19 PatientsStatus unknownNCT04375176
- Efficacy and Safety of Early COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 InfectionCompletedNCT04375098Phase 2
- Quantification of Radiological Pulmonary Involvement in Acute Respiratory FailureCompletedNCT04374734
- Risk of Venous Thromboembolism in Critically Ill Patients With Severe COVID-19CompletedNCT04374617
- Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19TerminatedNCT04371978Phase 3
- Observational Study of COVID-19 Treatment EfficacyTerminatedNCT04369989
- ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19CompletedNCT04367740
- African Covid-19 Critical Care Outcomes StudyStatus unknownNCT04367207
- Electrocardiogram Analysis in COVID-19 PatientsStatus unknownNCT04367129
- Study of the Pathogenesis of Olfactory Disorders in COVID-19CompletedNCT04366934
- Prevention and Treatment With Calcifediol of COVID-19 Induced Acute Respiratory SyndromeCompletedNCT04366908Phase 2
- Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19TerminatedNCT04366791Phase 1/2
- Ruxolitinib for the Treatment of Acute Respiratory Distress Syndrome in Patients With COVID-19 InfectionStatus unknownNCT04361903
- Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19)WithdrawnNCT04361461Phase 3
- Treatment Of CORONAVIRUS DISEASE 2019 (COVID-19) With Anti-Sars-CoV-2 Convalescent Plasma (ASCoV2CP)No longer availableNCT04360486
- Prone Positioning and Regional Ventilation in Mechanically Ventilated COVID-19 PatientsCompletedNCT04359407
- Risk Stratification With Chest CT to Rule-out Suspected SARS-CoV-2 InfectionsCompletedNCT04357938
- Antibody Seroprevalence and Rate of Asymptomatic Infections With SARS-CoV-2 in Austrian Hospital Personnel.CompletedNCT04354779
- Beaumont Health Large-scale Automated Serologic Testing for COVID-19CompletedNCT04349202
- Methylprednisolone in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome in Covid-19CompletedNCT04343729Phase 2
- Chloroquine Diphosphate in the Prevention of SARS in Covid-19 InfectionCompletedNCT04342650Phase 2
- Impact of Auricular Vagus Nerve Neuromodulation on COVID-19 Positive Inpatients OutcomeTerminatedNCT04341415Not applicable
- Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection DiseaseTerminatedNCT04335786Phase 4
- LIBERATE Trial in COVID-19WithdrawnNCT04334629Phase 4
- Treatment of SARS Caused by COVID-19 With RuxolitinibCompletedNCT04334044Phase 1/2
- Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDSCompletedNCT04333368Phase 1/2
- Household Transmission Investigation Study for COVID-19 in Tropical RegionsCompletedNCT04328129Not applicable
- A Longitudinal Study of COVID-19 Positive Patients Testing Nasal Swabs and Collecting Blood Samples for ResearchCompletedNCT04327804
- Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19TerminatedNCT04327505Phase 2/3
- Sero-epidemiological Study of the SARS-CoV-2 Virus Responsible for COVID-19 in FranceCompletedNCT04325646
- Cytokine Adsorption in Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane OxygenationCompletedNCT04324528Not applicable
- Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) TrialCompletedNCT04324463Phase 3
- Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2CompletedNCT04323527Phase 2
- An Observational Study of the Use of Siltuximab (SYLVANT) in Patients Diagnosed With COVID-19 Infection Who Have Developed Serious Respiratory ComplicationsCompletedNCT04322188
- The Efficacy of Different Anti-viral Drugs in COVID 19 Infected PatientsStatus unknownNCT04321616Phase 2/3
- Beaumont Quantitative Lung Function Imaging to Characterize Patients With SARS-COV 2TerminatedNCT04320511
- Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial)CompletedNCT04318015Phase 3
- Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial)CompletedNCT04315896Phase 3
- Acute Respiratory Failure and COVID-19 in Real LifeCompletedNCT04307459
- Stem Cell Educator Therapy Treat the Viral Inflammation in COVID-19Status unknownNCT04299152Phase 2
- Nitric Oxide Gas Inhalation for Severe Acute Respiratory Syndrome in COVID-19.WithdrawnNCT04290871Phase 2
- Streptokinase Versus Unfractionated Heparin Nebulization in Severe ARDSCompletedNCT03465085Phase 3
- Long-term Assessment of Organ Functions Among Survivors of Severe Acute Respiratory SyndromeStatus unknownNCT03443102
- Implementation of Lung Protective Ventilation in Patients With Acute Respiratory FailureCompletedNCT03225807
- Respiratory Virus Hospitalization Study (FLU 003 Plus)CompletedNCT01056185
- A Multi-centre, Double-blinded, Randomized, Placebo-controlled Trial on the Efficacy and Safety of Lopinavir / Ritonavir Plus Ribavirin in the Treatment of Severe Acute Respiratory SyndromeStatus unknownNCT00578825Not applicable
- Collection of Convalescent SARS Plasma by ApheresisCompletedNCT00342524
- Study of Alferon® LDO (Low Dose Oral) in Normal VolunteersCompletedNCT00215826Phase 2
- The Interaction Between Severe Acute Respiratory Distress Syndrome Viral Proteins and MonocytesWithdrawnNCT00172263Not applicable
- Contamination During Removal of Two Different Personal Protective SystemsCompletedNCT00150475Not applicable
- Evaluation and Treatment of Severe Acute Respiratory Syndrome (SARS)WithdrawnNCT00073086
- Investigating Severe Acute Respiratory Syndrome (SARS)CompletedNCT00066209